News Quantified

VKTX – viking therapeutics, inc. (US:NASDAQ)

Viking Therapeutics to Report Financial Results for First Quarter 2026 on April 29, 2026

4/22

06:09 am

vktx

Neutral

Viking Therapeutics (VKTX) had its "sell (d-)" rating reaffirmed by Weiss Ratings.

Assessing Viking Therapeutics (VKTX) Valuation As Obesity Trial Optimism Meets Richer Balance Sheet Ratios [Yahoo! Finance]

Better Long-Term Buy: Eli Lilly or Viking Therapeutics? [Globe and Mail, The (Toronto, Canada)]

Is Viking Therapeutics the Ultimate Millionaire-Maker Obesity Stock for 2026? [Yahoo! Finance]

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}